Please complete the CAPTCHA to continue
@alvotech.com
✓
2 phones found area 212
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Joseph Mcclellan is listed as Chief Scientific Officer at Alvotech at Alvotech, based in Ponte Vedra Beach, Florida, United States. AeroLeads shows a work email signal at alvotech.com, phone signal with area code 212, and a matched LinkedIn profile for Joseph Mcclellan.
Joseph Mcclellan previously worked as Chief Scientific Officer at Alvotech and Vice President, Head of Biosimilars Development at Pfizer. Joseph Mcclellan holds Ph.D., Chemistry And Mass Spectrometry from University Of Florida.
This section adds company-level context without repeating Joseph Mcclellan's masked contact details.
AeroLeads found 1 current-domain work email signal for Joseph Mcclellan. Compare company email patterns before reaching out.
• Insightful scientist and proven leader with extensive experience in driving forward R&D programs, while ensuring strategic and operational excellence• Outstanding track record in drug development with broad experience in all areas of biopharmaceutical development, including biosimilars, innovator biologics, pharmaceutical science, clinical development, and regulatory strategy• Keen manager of direct and indirect reports in matrix organizations• Key industry skills include: team leadership; biosimilars development; portfolio management, analysis, and solutions; clinical development; negotiation; collaboration; fiscal oversight and budget management; project management; biopharmaceutical drug development science; regulatory science and strategy; strategy development for biopharmaceutical process and product development; biopharmaceutical manufacturing; protein characterization, analytical chemistry, and mass spectrometry
Listed skills include Mass Spectrometry, Drug Development, Biopharmaceuticals, Analytical Chemistry, and 15 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Reykjavik, -, Is
Leads Alvotech's R&D functions, with overall responsibility for bringing products to market through our pipeline and overseeing R&D operations across company sites in Reykjavik, Julich, Hanover and Zurich.
New York, New York, Us
Lead the global development for the biosimilars portfolio within Pfizer Essential Health, Research & Development Manage, lead, and motivate the biosimilars development asset leaders to ensure that development programs are aligned with Essential Health R&D strategy and regulatory feedback/guidances on a global basis Asset Lead for the global development of Pfizer’s potential biosimilar for Remicade (infliximab)
New York, New York, Us
Lead the global development and business of Pfizer’s potential biosimilar for Remicade (infliximab), including non clinical and clinical development activities Final decision maker of the Hold Separate Team (HST) and Program Team and carry ultimate responsibility for the operational excellence of the program and the performance of the team Manage the Infliximab Divestment Business independently of Pfizer and in the best interest of the business with a view to ensuring its continued economic viability, marketability and competitiveness and its independence from the businesses retained by Pfizer
New York, New York, Us
Senior Director, Global R&D (2014 – 2015) Director, Global R&D (2011 – 2013) Led the global development of Pfizer’s potential biosimilar for Remicade (infliximab) Single point-of-accountability and point-of-contact for pre-clinical and clinical development activities related to infliximab asset Final decision maker of the asset team and carry ultimate responsibility for the operational excellence of the asset (program) and the performance of the asset team Created and maintained the integrated asset level development strategy incorporating development, medical, regulatory, and commercial considerations
New York, New York, Us
Led multiple Pfizer Worldwide Research & Development Teams comprising representatives from line functions across R&D during a project's lifecycle from Discovery through Clinical Proof of Concept Drove integrated, high-quality, efficient, and science-based biotherapeutic development for the global marketplace, while integrating cutting-edge concepts and best practices Effectively integrated science, technology, regulations, and market considerations into excellent development strategies that deliver meaningful and differentiated medicines Enabled and assured smooth line function interfaces by integrating activities to ensure that the integrated plan delivers on time, on scope and on budget
New York, New York, Us
Led multiple Project Teams comprising scientists from the key disciplines in Biotherapeutics R&D Pharmaceutical Sciences that are responsible for process and product development strategy, planning, execution Worked with key stakeholders across commercial, pre-clinical, clinical and manufacturing to define the product concept and led the operational planning for assigned projects
New York, New York, Us
Chaired multiple BioPharma Development Process and Product Development Project Teams Co-Led the BioPharma Development and Discovery Research Interface Technical Team Coordinated the authoring and review of Chemistry, Manufacturing, and Control sections of FIH IND/CTA regulatory documents, as well as responses to Board’s of Health inquiries
New York, New York, Us
Provided technical and scientific expertise in the development of protein therapeutic agents Collected, analyzed, and presented data for development projects to members of different cross-functional groups in the form of written technical reports and oral presentations Performed manufacturing comparability studies for clinical and commercial biotherapeutics Responsible for performance, data quality, and scientific development of direct reports
Boston, Ma, Us
Research Advisors: Joseph Zaia, Ph.D. and Catherine E. Costello, Ph.D. Applied cutting edge mass spectrometry techniques to solve critical questions in the life sciences as an investigator at a NIH National Center for Research Resources Conducted research on the fundamentals and applications of mass spectrometry for the analysis of proteins, glycoproteins, proteoglycans, peptides, and oligosaccharides and developed new methods for the identification and differentiation of glycosaminoglycans
Quick answers generated from the profile data available on this page.
Joseph Mcclellan works for Alvotech.
Joseph Mcclellan is listed as Chief Scientific Officer at Alvotech at Alvotech.
AeroLeads has found 1 work email signal at @alvotech.com for Joseph Mcclellan at Alvotech.
AeroLeads has found 2 phone signal(s) with area code 212 for Joseph Mcclellan at Alvotech.
Joseph Mcclellan is based in Ponte Vedra Beach, Florida, United States while working with Alvotech.
Joseph Mcclellan has worked for Alvotech, Pfizer, and Boston University School Of Medicine.
You can use AeroLeads to view verified contact signals for Joseph Mcclellan at Alvotech, including work email, phone, and LinkedIn data when available.
Joseph Mcclellan holds Ph.D., Chemistry And Mass Spectrometry from University Of Florida.
Joseph Mcclellan is listed with skills including Mass Spectrometry, Drug Development, Biopharmaceuticals, Analytical Chemistry, Biotechnology, Chemistry, Lifesciences, and Project Portfolio Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts